News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Alnylam Pharmaceuticals
NEWS
JOBS
IN THE PRESS
NEWS
Genetown
10 Massachusetts Biotechs Devoting the Most Cash to R&D
May 5, 2016
·
3 min read
Job Trends
Alnylam Breaks Ground on New $200 Million Manufacturing Facility in Massachusetts, Adding 150 Jobs
April 28, 2016
·
4 min read
Drug Development
Alnylam’s John Maraganore Provides Leadership for RNAi Development and Biotech Industry
April 1, 2016
·
7 min read
Drug Development
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015
March 23, 2016
·
3 min read
Deals
Three Potential Takeover Targets for Amgen
March 10, 2016
·
3 min read
Job Trends
Alnylam to Build $200 Million Site in Massachusetts that Will Employ 200+ Workers
February 12, 2016
·
2 min read
Job Trends
Alnylam’s Human Resources Boss Provides Hiring Strategy, Planning to Hire 1,500 By 2020
December 9, 2015
·
3 min read
Deals
Why Amgen Should Turn Its Attention to Alnylam
November 13, 2015
·
3 min read
Policy
Alnylam Slaps Dicerna With Trade Secret Lawsuit
June 11, 2015
·
4 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Alnylam to Host Tenth “RNAi Roundtable” Webcast Series
June 12, 2026
·
4 min read
Press Releases
GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region
June 10, 2026
·
3 min read
Press Releases
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
June 4, 2026
·
7 min read
Press Releases
Alnylam Issues 2025 Corporate Responsibility Report
May 19, 2026
·
4 min read
Press Releases
New Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutrisiran as a First-Line Treatment Option Across ATTR-CM Patient Populations, Including Patients with a High Disease Burden
May 12, 2026
·
10 min read
Press Releases
Alnylam to Webcast Presentations at Upcoming Investor Conferences - May 7, 2026
May 7, 2026
·
1 min read
Press Releases
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM
May 4, 2026
·
9 min read
Press Releases
Alnylam Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Period Progress
April 30, 2026
·
19 min read
Press Releases
Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2-Associated ARVC at ASGCT 2026
April 27, 2026
·
9 min read
Press Releases
Alnylam to Webcast Conference Call Discussing First Quarter 2026 Financial Results
April 17, 2026
·
1 min read
